Cargando…
PPM1A as a key target of the application of Jiawei-Maxing-Shigan decoction for the attenuation of radiation-induced epithelial-mesenchymal transition in type II alveolar epithelial cells
Radiation-induced lung tissue injury is an important reason for the limited application of radiotherapy on thoracic malignancies. Previously, we reported that administration of Jiawei-Maxing-Shigan decoction (JMSD) attenuated the radiation-induced epithelial-mesenchymal transition (EMT) in alveolar...
Autores principales: | Lu, Jinhua, Lin, Shengyou, Lin, Zechen, Lin, Xianlei, Shen, Yuezhong, Su, Jingyang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8485126/ https://www.ncbi.nlm.nih.gov/pubmed/34558633 http://dx.doi.org/10.3892/mmr.2021.12465 |
Ejemplares similares
-
Application of Jiawei Maxing Shigan Tang in the treatment of COVID-19: An observational study
por: Wu, Jia, et al.
Publicado: (2022) -
Jiawei Xianglian Decoction (JWXLD), a Traditional Chinese Medicine (TCM), Alleviates CPT-11-Induced Diarrhea in Mice
por: Lu, Jinhua, et al.
Publicado: (2020) -
Maxing Shigan Decoction Mitigates Mycoplasma pneumonia-Induced Pyroptosis in A549 Cells via the NLRP3 Inflammasome
por: Liu, Fang, et al.
Publicado: (2021) -
Potential effect of Maxing Shigan decoction against coronavirus disease 2019 (COVID-19) revealed by network pharmacology and experimental verification
por: Li, Yuan, et al.
Publicado: (2021) -
Efficacy and safety of Maxing Shigan Decoction in the treatment of chronic obstructive pulmonary disease: A protocol for a systematic review and meta-analysis
por: Chen, Jinyun, et al.
Publicado: (2020)